Variant report
Variant | nsv967588 |
---|---|
Chromosome Location | chr8:50650796-50653401 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563537915 | chr8:50650823-50650824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572989222 | chr8:50650839-50650840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542738929 | chr8:50650843-50650844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561365117 | chr8:50650847-50650848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186344112 | chr8:50650864-50650865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114093658 | chr8:50650867-50650868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538108815 | chr8:50650877-50650878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565981891 | chr8:50650878-50650879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533259546 | chr8:50650885-50650886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551640688 | chr8:50650937-50650938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184595574 | chr8:50650938-50650939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117632930 | chr8:50650965-50650966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs369395510 | chr8:50651015-50651016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555192602 | chr8:50651048-50651049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567319715 | chr8:50651076-50651077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534330221 | chr8:50651137-50651138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569172401 | chr8:50651141-50651142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552507210 | chr8:50651152-50651153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577965990 | chr8:50651154-50651155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538937952 | chr8:50651196-50651197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189430281 | chr8:50651197-50651198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575729601 | chr8:50651204-50651205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543180752 | chr8:50651219-50651220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561243138 | chr8:50651314-50651315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181473149 | chr8:50651315-50651316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540675803 | chr8:50651320-50651321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76583288 | chr8:50651360-50651361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149888207 | chr8:50651436-50651437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550011650 | chr8:50651454-50651455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563546523 | chr8:50651459-50651460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184984394 | chr8:50651476-50651477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189107917 | chr8:50651526-50651527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78969650 | chr8:50651531-50651532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369060388 | chr8:50651575-50651576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181720711 | chr8:50651606-50651607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546230876 | chr8:50651616-50651617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570896116 | chr8:50651617-50651618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79942455 | chr8:50651686-50651687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79587164 | chr8:50651709-50651710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575863495 | chr8:50651749-50651750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536456642 | chr8:50651756-50651757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186421739 | chr8:50651759-50651760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145930498 | chr8:50651786-50651787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552626391 | chr8:50651812-50651813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139878492 | chr8:50651861-50651862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537708328 | chr8:50651951-50651952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs199867673 | chr8:50651952-50651953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191136921 | chr8:50651956-50651957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577332629 | chr8:50652016-50652017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544583206 | chr8:50652040-50652041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:50646200-50651600 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr8:50651600-50651800 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr8:50651800-50654200 | Weak transcription | H1 Cell Line | embryonic stem cell |